Literature DB >> 1345816

Clinical features of the idiopathic long QT syndrome.

A J Moss1, J Robinson.   

Abstract

Long QT syndrome (LQTS) is an infrequently occurring familial disorder in which affected members have electrocardiographic QT interval prolongation and a propensity to syncope and fatal ventricular arrhythmias. This review of the current literature includes discussions of inheritance, clinical presentation, diagnosis, and treatment of LQTS. At present, there are three modalities of treatment for LQTS patients: beta-blockers, pacemakers, and left cervicothoracic sympathetic ganglionectomy. Because the clinical course of LQTS is quite variable, therapy must be individualized for each patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1345816

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  DNA fragmentation in leukocytes following subacute low-dose nerve agent exposure.

Authors:  J R Moffett; R A Price; S M Anderson; M L Sipos; A V Moran; F C Tortella; J R Dave
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

Review 2.  The molecular autopsy: should the evaluation continue after the funeral?

Authors:  David J Tester; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

3.  Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype.

Authors:  Anna-Mari Hekkala; Heikki Swan; Matti Viitasalo; Heikki Väänänen; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

Review 4.  Chest pain in children.

Authors:  I C Balfour; P S Rao
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

Review 5.  Early identification of risk factors for sudden cardiac death.

Authors:  Sumeet S Chugh
Journal:  Nat Rev Cardiol       Date:  2010-04-27       Impact factor: 32.419

6.  Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management.

Authors:  Giovanni Fazio; Federica Vernuccio; Giuseppe Grutta; Giuseppe Lo Re
Journal:  World J Cardiol       Date:  2013-04-26

Review 7.  Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.

Authors:  Rainer Schimpf; Christian Veltmann; Christian Wolpert; Martin Borggrefe
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

8.  Risk of death in the long QT syndrome when a sibling has died.

Authors:  Elizabeth S Kaufman; Scott McNitt; Arthur J Moss; Wojciech Zareba; Jennifer L Robinson; W Jackson Hall; Michael J Ackerman; Jesaia Benhorin; Emanuela T Locati; Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Jeffrey A Towbin; G Michael Vincent; Li Zhang
Journal:  Heart Rhythm       Date:  2008-03-04       Impact factor: 6.343

9.  Age-and sex-dependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2.

Authors:  Ewa Moric-Janiszewska; Joanna Głogowska-Ligus; Monika Paul-Samojedny; Ludmiła Węglarz; Grażyna Markiewicz-Łoskot; Lesław Szydłowski
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

10.  Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.

Authors:  Francesca Stillitano; Jens Hansen; Chi-Wing Kong; Ioannis Karakikes; Christian Funck-Brentano; Lin Geng; Stuart Scott; Stephan Reynier; Ma Wu; Yannick Valogne; Carole Desseaux; Joe-Elie Salem; Dorota Jeziorowska; Noël Zahr; Ronald Li; Ravi Iyengar; Roger J Hajjar; Jean-Sébastien Hulot
Journal:  Elife       Date:  2017-01-30       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.